''Head-to-side-chain'' cyclic tripeptides were designed as endothelin receptor antagonists. Solid phase synthesis of cyclic peptides, using an automated allyl cleavage procedure with Pd[P(Ph(3))](4) followed by cyclization was performed. Synthetic procedures were established on a continous-flow peptide synthesizer. (C) 1997, Published by Elsevier Science Ltd.